Terms: = Bone cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Prognosis
12 results:
1. Diagnosis- and prognosis-Related Gene Alterations in
Morishita S; Komatsu N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
[No Abstract] [Full Text] [Related]
2. High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis.
Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Mroczkowska-Bękarciak A; Sobas M; Lewandowski K
J Appl Genet; 2023 Sep; 64(3):479-491. PubMed ID: 37507589
[TBL] [Abstract] [Full Text] [Related]
3. Hitting the brakes on accelerated and blast-phase myeloproliferative neoplasms: current and emerging concepts.
Bewersdorf JP; Rampal RK
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):218-224. PubMed ID: 36485103
[TBL] [Abstract] [Full Text] [Related]
4. JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.
Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Lewandowski K
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4789-4803. PubMed ID: 36242602
[TBL] [Abstract] [Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.
Song GY; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Choi SH; Kim MY; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Zhang Z; Ahn JS; Kim HJ; Kim DDH
Bone Marrow Transplant; 2022 Dec; 57(12):1810-1819. PubMed ID: 36151367
[TBL] [Abstract] [Full Text] [Related]
6. Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape.
Tefferi A; Gangat N; Pardanani A; Crispino JD
Cancer Res; 2022 Mar; 82(5):749-763. PubMed ID: 34911786
[TBL] [Abstract] [Full Text] [Related]
7. Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
Bersanelli M; Travaglino E; Meggendorfer M; Matteuzzi T; Sala C; Mosca E; Chiereghin C; Di Nanni N; Gnocchi M; Zampini M; Rossi M; Maggioni G; Termanini A; Angelucci E; Bernardi M; Borin L; Bruno B; Bonifazi F; Santini V; Bacigalupo A; Voso MT; Oliva E; Riva M; Ubezio M; Morabito L; Campagna A; Saitta C; Savevski V; Giampieri E; Remondini D; Passamonti F; Ciceri F; Bolli N; Rambaldi A; Kern W; Kordasti S; Sole F; Palomo L; Sanz G; Santoro A; Platzbecker U; Fenaux P; Milanesi L; Haferlach T; Castellani G; Della Porta MG
J Clin Oncol; 2021 Apr; 39(11):1223-1233. PubMed ID: 33539200
[TBL] [Abstract] [Full Text] [Related]
8. Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutation.
Mannina D; Gagelmann N; Badbaran A; Ditschkowski M; Bogdanov R; Robin M; Cassinat B; Heuser M; Shahswar R; Thol F; Beelen D; Kröger N
Eur J Haematol; 2019 Dec; 103(6):552-557. PubMed ID: 31446640
[TBL] [Abstract] [Full Text] [Related]
9. Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes.
Shingai N; Harada Y; Iizuka H; Ogata Y; Doki N; Ohashi K; Hagihara M; Komatsu N; Harada H
Int J Hematol; 2018 Dec; 108(6):598-606. PubMed ID: 30353274
[TBL] [Abstract] [Full Text] [Related]
10. Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature.
Zhou A; Afzal A; Oh ST
Curr Hematol Malig Rep; 2017 Oct; 12(5):397-405. PubMed ID: 28948488
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.
Nazha A; Bejar R
Curr Hematol Malig Rep; 2017 Oct; 12(5):461-467. PubMed ID: 28844082
[TBL] [Abstract] [Full Text] [Related]
12. Primary Spinal Tumor Mortality Score (PSTMS): a novel scoring system for predicting poor survival.
Szövérfi Z; Lazary A; Bozsódi Á; Klemencsics I; Éltes PE; Varga PP
Spine J; 2014 Nov; 14(11):2691-700. PubMed ID: 24650850
[TBL] [Abstract] [Full Text] [Related]